Assignee
ENYO PHARMA
FR·8 granted patents·13 pending applications·4 citations·filing 2017–2024
Top patents by PatentIndex Score
21 records- 0185US12030861B1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2023·Granted Jul 9, 2024·2 cites·48 claims
- 0279US11492347B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Nov 8, 2022·1 cites·12 claims
- 0370US11279683B2Thiophene derivatives as antiviral agentsENYO PHARMA·Filed 2017·Granted Mar 22, 2022·1 cites·9 claims
- 0466US2025019358A1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2024·Application pending·0 cites
- 0563US11807618B2Thiophene derivatives as antiviral agentsENYO PHARMA·Filed 2022·Granted Nov 7, 2023·0 cites·7 claims
- 0660US11603368B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Mar 14, 2023·0 cites·2 claims
- 0759US11840527B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Dec 12, 2023·0 cites·8 claims
- 0858US11767316B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Sep 26, 2023·0 cites·9 claims
- 0956US2024216364A1Strong potentiation of tlr3 agonists effects using fxr agonists as a combined treatmentENYO PHARMA·Filed 2022·Application pending·0 cites
- 1056US2025019370A1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2024·Application pending·0 cites
- 1152US2023165853A1Method for treating chronic kidney diseasesENYO PHARMA·Filed 2022·Application pending·0 cites
- 1251US2024100125A1Synergistic effect of a fxr agonist and ifn for the treatment of hbv infectionENYO PHARMA·Filed 2022·Application pending·0 cites
- 1351US2023321033A1Thiophen compounds for use in the treatment of renal fibrosisENYO PHARMA·Filed 2021·Application pending·0 cites
- 1450US2022251028A1Tertiary amine derivatives and their uses for treating a viral infectionENYO PHARMA·Filed 2020·Application pending·0 cites
- 1550US2024156778A1Thiophene derivatives for use in treating portal inflammation and fibrosisENYO PHARMA·Filed 2020·Application pending·0 cites
- 1648US2024002370A1Pyrrole-type compounds and uses thereof for treating viral infectionsENYO PHARMA·Filed 2021·Application pending·0 cites
- 1748US2023150978A1Quinazolinone derivatives and uses thereof for treating a cancerENYO PHARMA·Filed 2021·Application pending·0 cites
- 1846US2021038566A1Use of modulators of neet proteins for the treatment of infectionENYO PHARMA·Filed 2019·Application pending·0 cites
- 1945US12551480B2Treatment using EYP001ENYO PHARMA·Filed 2020·Granted Feb 17, 2026·0 cites·13 claims
- 2044US2022313690A1Synergistic effect of eyp001 and ifn for the treatment of hbv infectionENYO PHARMA·Filed 2020·Application pending·0 cites
- 2143US2022241376A1Method for decreasing adverse-effects of interferonENYO PHARMA·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →